MUC4 and its membrane partner the oncogenic receptor ErbB2 interact physically in pancreatic cancer cells [81], and silencing of ErbB2 results in enhanced gemcitabine sensitivity via upregulation of hCNT1 and hCNT3 expression [82]. Here, SLC28A3 is linked to familial pancreatic carcinoma.